Skip to main content
Premium Trial:

Request an Annual Quote

Montreal Researchers Win Leukemia, Lymphoma Grants

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Cole Foundation has awarded C$700,000 ($720,000) in new grants to researchers at the University of Montreal and McGill University to fund a range of studies focused on leukemia and lymphoma that affects people under the age of 25, the University of Montreal said Tuesday.

The fellowship grants to 14 young researchers will support genomics and molecular biology-based research aimed at discovering new ways to understand and diagnose these diseases.

"Acute lymphoblastic leukemia, or ALL, is the most frequent cancer in children, accounting for approximately 25 percent of all pediatric tumors," said fellowship recipient and University of Montreal researcher Andrea Alter, in a statement.

"Using next-generation sequencing technology, we will examine all gene sequences in a well-characterized group of ALL patients to identify leukemia-specific errors in DNA sequences. Subsequently, we will study the impact of these leukemia-specific mutations on disease susceptibility and disease initiation," Alter continued.

Another fellowship recipient at the University of Montreal, Richard Bisaillon, will study the molecular mechanisms involved in functioning and development of acute myeloid leukemias. At McGill University, researcher Sayeh Davoudi at the Goodman Cancer Research Center will study the role of polymerase in the generation of point mutations, and Gabriela Galicia Vazquez will study a eukaryotic initiation factor as a molecular target for lymphoma treatment.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more